Publications - 'E'
Publications 801 - 825 de 2582
| Titre | DOI |
|---|---|
|
Efficacy and Tolerance of Interferon-alpha in Hypereosinophilic Syndromes. a Retrospective Multicenter Study on 29 Patients P. De Malglaive; M. Groh; G. Lefevre; C.Morati Hafsaoui; M. Alexis; M. Hunault; J. Seneschal; H. Charlanne; C. Preudhomme; B. Bonnotte; J.Emmanuel Kahn 2019 |
10.1182/blood-2019-131687 |
|
Efficacy and Tolerance of Rituximab in IgG4-Related Disease: A Retrospective Multicentric Study in 24 Patients M. Ebbo; A. Grados; M. Samson; C. Carra-Dalliere; A. Pozdzik; P. Labauge; S. Palat; J.M. Berthelot; J.L. Pennaforte; A. Wynckel; C. Lebas; T. Quemeneur; K. Dahan; J.J. Boffa; B. Godeau; N. Limal; F. Carbonnel; A. Herber; G. Leroux; P. Cacoub; A. Mathian; E. Hachulla; N. Costedoat-Chalumeau; J.R. Harle; N. Schleinitz 2015 |
|
|
Efficacy and toxicity of second-line chemotherapy in patients with advanced oesophageal squamous cell carcinoma progressing after a first line of 5-fluorouracil and platinum-based therapy: An AGEO retrospective multicentric study C. Auzolle; O. Dubreuil; A. Pozet; R. Coriat; M. Dhooge; M. Ducreux; M. Mons; B. Brieau; I. Baumgaertner; J.M. Gornet; A. Lievre; C. Locher; F. Mary; F. Bonnetain; B. Landi 2015 |
10.1016/S0959-8049(16)31232-1 |
|
Efficacy of a docetaxel-5FU-oxaliplatin regimen (TEFOX) in first-line treatment of advanced gastric signet ring cell carcinoma: an AGEO multicentre study S. Pernot; O. Dubreuil; T. Aparicio; K. Le Malicot; D. Tougeron; C. Lepere; C. Lecaille; L. Marthey; J. Palle; J.B. Bachet; A. Zaanan; J. Taieb 2018 |
10.1038/s41416-018-0133-7 |
|
Efficacy of a general practitioner training campaign for early detection of melanoma in France F. Grange; A.S. Woronoff; R. Bera; M. Colomb; B. Lavole; E. Fournier; F. Arnold; C. Barbe 2014 |
10.1111/bjd.12585 |
|
Efficacy of a hand protection cream used alone followed by in a regimen in subjects with occupational irritant contact dermatitis P. Humbert; F. Fanian; M.H. Meckfessel; M. Grivet-Seyve 2017 |
|
|
Efficacy of a hand protection cream used alone followed by in a regimen in subjects with occupational irritant contact dermatitis P. Humbert; F. Fanian; M.H. Meckfessel; M. Grivet-Seyve 2017 |
|
|
Efficacy of a motorized air support to prevent pressure ulcers in at-risk patients hospitalized in rehabilitation departments: incidence and prevalence studies Y. Sturm; V. Delobbe; F.A. Allaert; E. Pot; B. Perrin; L. Goita; Y. Druelle; S. Aufaure 2019 |
10.23736/S0031-0808.18.03592-9 |
|
Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo(A (R))) in Achieving Intramuscular Agent Delivery: An Observational Study M. Bardou; M. Luu; P. Walker; C. Auriel; X. Castano 2017 |
10.1007/s12325-016-0452-0 |
|
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study D. Tougeron; G. Mouillet; I. Trouilloud; T. Lecomte; R. Coriat; T. Aparicio; G.Des Guetz; C. Lecaille; P. Artru; G. Sickersen; E. Cauchin; D. Sefrioui; T. Boussaha; A. Ferru; T. Matysiak-Budnik; C. Silvain; L. Karayan-Tapon; J.C. Pages; D. Vernerey; F. Bonnetain; P. Michel; J. Taieb; A. Zaanan 2016 |
10.1093/jnci/djv438 |
|
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first-line therapy for metastatic colorectal cancer: GERCOR VELVET phase II study B. Chibaudel; J.B. Bachet; T. Andre; D. Auby; J. Desrame; G. Deplanque; C. Lecaille; C. Louvet; C. Tournigand; V. Lebrun-Ly; J. Dauba; G. Lledo; M.L. Garcia; O. Dubreuil; N.Baba Hamed; A. Meurisse; A.K. Larsen; A. Tijeras-Raballand; F. Bonnetain; A. de Gramont 2019 |
10.3892/ijo.2019.4709 |
|
Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers L. Bignon; J.P. Fricker; C. Nogues; E. Mouret-Fourme; D. Stoppa-Lyonnet; O. Caron; A. Lortholary; L. Faivre; C. Lasset; V. Mari; P. Gesta; L. Gladieff; A. Hamimi; T. Petit; M. Velten 2018 |
10.1111/tbj.12887 |
|
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial Origin A. Zaanan; J. Henriques; R. Cohen; D. Sefrioui; C. Evrard; C. de la Fouchardiere; T. Lecomte; T. Aparicio; M. Svrcek; J. Taieb; T. Andre; D. Vernerey; D. Tougeron; A.Gastroent Oncologu 2021 |
10.1093/jnci/djaa072 |
|
Efficacy of anti-TNF alpha in severe and/or refractory Behcet's disease: Multicenter study of 124 patients H. Vallet; S. Riviere; A. Sanna; A. Deroux; G. Moulis; O. Addimanda; C. Salvarani; M. Lambert; P. Bielefeld; P. Seve; J. Sibilia; J. Pasquali; J. Fraison; I. Marie; L. Perard; L. Bouillet; F. Cohen; D. Sene; Y. Schoindre; O. Lidove; P. Le Hoang; E. Hachulla; O. Fain; X. Mariette; T. Papo; B. Wechsler; B. Bodaghi; R. Rigon; P. Cacoub; D. Saadoun; F.Behcet Network 2015 |
10.1016/j.jaut.2015.06.005 |
|
Efficacy of Azacitidine (AZA) in Autoimmune and Inflammatory Disorders (AID) Associated with Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) J.B. Fraison; A. Mekinian; E. Grignano; J.E. Kahn; J.B. Arlet; O. Decaux; D. Guillaume; A.L. Buchdahl; M. Omouri; G. Maigne; A. Aouba; N. Leon; S. Berthier; E. Liozon; S. Park; C. Gardin; O. Lortholary; J. Rossignol; P. Fenaux; O. Fain; T. Braun 2015 |
10.1182/blood.V126.23.1695.1695 |
|
EFFICACY OF AZACITIDINE (AZA) IN AUTOIMMUNE DISORDERS (AID) ASSOCIATED WITH MDS J.B. Fraison; A. Mekinian; E. Grignano; J.E. Kahn; J.B. Arlet; M. Silva; S. Berthier; E. Liozon; G. Denis; A.L. Buchdahl; M. Omouri; B. Grosbois; S. Park; A. Bourgarit-Durand; J. Rossignol; P. Fenaux; O. Fain; T. Braun 2015 |
10.1016/S0145-2126(15)30281-2 |
|
Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia J.B. Fraison; A. Mekinian; E. Grignano; J.E. Kahn; J.B. Arlet; O. Decaux; G. Denis; A.L. Buchdahl; M. Omouri; G. Maigne; A. Aouba; N. Leon; S. Berthier; E. Liozon; S. Park; C. Gardin; O. Lortholary; J. Rossignol; P. Fenaux; O. Fain; T. Braun 2016 |
10.1016/j.leukres.2016.02.005 |
|
Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model S. Albac; M. Medina; D. Labrousse; D. Hayez; D. Bonnot; N. Anzala; F. Laurent; T. Ferry; A. Dublanchet; P. Chavanet; C. Fevre; D. Croisier 2020 |
10.1128/AAC.01870-19 |
|
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients A. Mekinian; C. Comarmond; M. Resche-Rigon; T. Mirault; J.Emmanuel Kahn; M. Lambert; J. Sibilia; A. Neel; P. Cohen; M. Hie; S. Berthier; I. Marie; C. Lavigne; M.Anne Vandenhende; G. Muller; Z. Amoura; H. Devilliers; S. Abad; M. Hamidou; L. Guillevin; R. Dhote; B. Godeau; E. Messas; P. Cacoub; O. Fain; D. Saadoun; F.Takayasu Network 2015 |
10.1161/CIRCULATIONAHA.114.014321 |
|
Efficacy of biologics in psoriasis patients under hemodialysis M. Larquey; C. Girard; E. Sbidian; M.A. Richard; F. Aubin; J.L. Schmutz 2017 |
10.1684/ejd.2017.3064 |
|
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers C. Rossi; J. Gilhodes; M. Maerevoet; C. Herbaux; F. Morschhauser; P. Brice; S. Garciaz; C. Borel; L. Ysebaert; L. Oberic; J. Lazarovici; B. Deau; J. Dupuis; A. Chauchet; J. Abraham; F. Bijou; A. Stamatoullas-Bastard; J.V. Malfuson; C. Golfier; C. Laurent; S. Pericart; A. Traverse-Glehen; S. Kanoun; T. Filleron; R.O. Casasnovas; H. Ghesquieres 2018 |
10.1002/ajh.25154 |
|
Efficacy of chemotherapy plus bevacizumab in recurrent multiforme glioblastoma: A real-life study A.V.A. Beige; F. Ghiringhelli; J. Vincent; J. Lecuelle; C. Truntzer; W. Farah; F. Borsotti; I. Mazilu; S.M. Ilie 2021 |
10.1016/j.annonc.2021.08.025 |
|
Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature Review S. Deshayes; S. Georgin-Lavialle; A. Hot; C.A. Durel; E. Hachulla; N. Rouanes; S. Audia; T. Le Gallou; P. Quartier; G. Urbanski; L. Messer; S. Klein; H. de Boysson; B. Bienvenu; G. Grateau; A. Aouba 2018 |
10.3899/jrheum.170684 |
|
EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM P. Peterlin; P. Turlure; P. Chevallier; M.P. Gourin; P.Y. Dumas; S. Thepot; A. Berceanu; S. Park; M.A. Hospital; T. Cluzeau; J.M. Torregrossa-Diaz; L. Devron; R. Sapena; F. Chermat; S. Dimicoli-Salazar; P. Fenaux 2021 |
|
|
Efficacy of deep sedation for patients with intractable electrical storm refractory to anti-arrhythmic drugs R. Martins; J.M. Urien; N. Barbarot; J.M. Sellal; N. Clementy; C. Guenancia; E. Gandjbakhch; J. Duchateau; D. Hamon; L. Champ-Rigot; E. Marijon; R. Garcia; C. De Chillou; F. Sacher; V. Galand 2020 |